CAS 157-03-9: 6-Diazo-5-oxo-L-norleucine
Formula:C6H9N3O3
InChI:InChI=1S/C6H9N3O3/c7-5(6(11)12)2-1-4(10)3-9-8/h3,5H,1-2,7H2,(H,11,12)/t5-/m0/s1
InChI key:InChIKey=YCWQAMGASJSUIP-YFKPBYRVSA-N
SMILES:[N-]=[N+]=CC(=O)CCC(N)C(=O)O
- Synonyms:
- (1E,5S)-5-amino-5-carboxy-1-diazoniopent-1-en-2-olate
- (1Z,5S)-5-amino-5-carboxy-1-diazoniopent-1-en-2-olate
- (2S)-2-Amino-6-diazo-5-oxohexanoic acid
- 5-Amino-5-Carboxy-1-Diazoniopent-1-En-2-Olate
- 6-Diazen-1-Iumylidene-5-Oxonorleucine
- 6-Diazo-5-oxo-<span class="text-smallcaps">L</span>-norleucine
- <span class="text-smallcaps">L</span>-6-Diazo-5-oxonorleucine
- <span class="text-smallcaps">L</span>-DON
- <span class="text-smallcaps">L</span>-Norleucine, 6-diazo-5-oxo-
- DON (pharmaceutical)
- See more synonyms
- H-6-Diazo-5-oxo-Nle-OH
- NSC 7365
- Norleucine, 6-diazo-5-oxo-, <span class="text-smallcaps">L</span>-
- DON
- 6-Diazo-5-oxo-L-norleucine
- Norleucine, 6-diazo-5-oxo-, L-
- L-Norleucine, 6-diazo-5-oxo-

L-Norleucine, 6-diazo-5-oxo-
CAS:157-03-9
Formula:
C6H9N3O3
Purity:
99%
Color and Shape:
Solid
Molecular weight:
171.1540
Ref: IN-DA001P53
1mg | 280.00 € | ||
5mg | 550.00 € | ||
50mg | 640.00 € | ||
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Monday 10 Mar 2025

6-Diazo-5-oxo-L-norleucine
CAS:157-03-9
Formula:
C6H9N3O3
Purity:
≥ 95.0%
Color and Shape:
Light yellow crystalline powder
Molecular weight:
171.15
Ref: 7W-GA1424
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 11 Mar 2025

6-Diazo-5-oxo-L-nor-Leucine
CAS:157-03-9
6-Diazo-5-oxo-L-nor-Leucine (L-6-Diazo-5-oxonorleucine) is an antagonist of glutaminases (Ki : 6 μM).
Formula:
C6H9N3O3
Purity:
98.04% - 98.93%
Color and Shape:
Solid
Molecular weight:
171.15
- Inhibitors
- Glutaminase
- Antibiotic
- Influenza Virus
- See more categories
- Other Inhibitors
- Antibiotics
Ref: TM-T8373
1mg | 48.00 € | ||
5mg | 120.00 € | ||
10mg | 173.00 € | ||
25mg | 283.00 € | ||
50mg | 434.00 € | ||
100mg | 635.00 € | ||
1mL*10mM (DMSO) | 88.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025

6-Diazo-5-oxo-L-norleucine
Controlled ProductCAS:157-03-9
Formula:
C6H9N3O3
Color and Shape:
Light Yellow
Molecular weight:
171.15
Ref: TR-D679273
1mg | 120.00 € | ||
5mg | 405.00 € | ||
10mg | 724.00 € |
Estimated delivery in United States, on Tuesday 18 Mar 2025

6-Diazo-5-oxo-L-norleucine
CAS:157-03-9
Inhibitor of hexosamine biosynthetic pathway
Formula:
C6H9N3O3
Purity:
Min. 95%
Color and Shape:
Slightly Yellow Powder
Molecular weight:
171.15 g/mol
Ref: 3D-FD49029
1g | 5,633.00 € | ||
2g | 7,511.00 € | ||
5g | 10,640.00 € | ||
10g | 13,769.00 € |
Estimated delivery in United States, on Monday 5 May 2025

H-6-Diazo-5-oxo-Nle-OH
CAS:157-03-9
L-DON, which corresponds to Glu γ-diazomethyl ketone, inactivates rat renal phosphate-dependent glutaminase and is active …
Formula:
C6H9N3O3
Purity:
> 95%
Color and Shape:
Light Beige
Molecular weight:
171.16
Ref: 01-4006579
100mg | Discontinued | Request information | |
500mg | Discontinued | Request information |

Ref: 10-F493027
5mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |